This protocol is judged by an institutional evaluation board, an impartial team that testimonials any scientific trials involving individuals. If a research involves a Schedule I drug, after the board approves the protocol as moral, the scientists have to make an application for an investigational new drug (IND) number through the FDA.Entry to ill